Merck CEO Search Expands: Is Company Now A Turnaround Story?
This article was originally published in The Tan Sheet
Executive Summary
Merck is broadening its CEO succession search while revising the job description to take into account the challenges posed by the Vioxx withdrawal
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning